Joel D Leverson Selected Research

Oncogene Proteins (Oncogene Protein)

1/2021

Venetoclax Increases Intratumoral Effector T Cells and Antitumor Efficacy in Combination with Immune Checkpoint Blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joel D Leverson Research Topics

Disease

37	Neoplasms (Cancer) 01/2022 - 04/2005
11	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023 - 02/2013
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 03/2014
7	Multiple Myeloma 12/2023 - 10/2015
5	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 11/2009
5	Leukemia 01/2020 - 03/2015
4	Lymphoma (Lymphomas) 01/2020 - 02/2013
4	Lung Neoplasms (Lung Cancer) 11/2018 - 01/2015
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 07/2015
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2022 - 01/2022
2	Carcinogenesis 01/2021 - 04/2005
2	Breast Neoplasms (Breast Cancer) 01/2019 - 08/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Disease Progression 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Synovial Sarcoma (Synovioma) 05/2021
1	Triple Negative Breast Neoplasms 11/2020
1	Hypersensitivity (Allergy) 01/2019
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016
1	Lymphadenopathy 10/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2015
1	Colorectal Neoplasms (Colorectal Cancer) 07/2015
1	Neutropenia 03/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2014
1	Thrombocytopenia (Thrombopenia) 10/2014
1	Genomic Instability 09/2007
1	Weight Loss (Weight Reduction) 06/2005

Drug/Important Bio-Agent (IBA)

27	venetoclaxIBA 12/2023 - 02/2013
17	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2007
16	navitoclaxIBA 01/2022 - 12/2011
3	Phosphotransferases (Kinase)IBA 11/2018 - 06/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 01/2018
2	Apoptosis Regulatory ProteinsIBA 01/2022 - 01/2018
2	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2005
2	cobimetinibIBA 01/2020 - 01/2019
2	Small Interfering RNA (siRNA)IBA 08/2015 - 04/2005
2	A-1155463IBA 07/2015 - 10/2014
2	Docetaxel (Taxotere)FDA Link 03/2015 - 01/2015
1	Mevalonic Acid (Mevalonate)IBA 12/2023
1	SenotherapeuticsIBA 01/2022
1	enasidenibIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2021
1	ibrutinibIBA 12/2021
1	MTOR InhibitorsIBA 11/2021
1	S63845IBA 05/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 11/2020
1	ABT-414IBA 11/2020
1	A-1331852IBA 10/2020
1	Etoposide (VP 16)FDA LinkGeneric 10/2020
1	CytokinesIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Drug CombinationsIBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	olaparibIBA 01/2019
1	EWS-FLI fusion proteinIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	Coenzyme A (CoA)IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Myeloid Cell Leukemia Sequence 1 ProteinIBA 11/2017
1	Bortezomib (Velcade)FDA Link 01/2016
1	bcr-abl Fusion ProteinsIBA 01/2016
1	A-1210477IBA 08/2015
1	alvocidib (flavopiridol)IBA 08/2015
1	CamptothecinIBA 01/2015
1	BenzimidazolesIBA 01/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2009
1	UbiquitinIBA 09/2007
1	Glucose (Dextrose)FDA LinkGeneric 06/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2005
1	Sirolimus (Rapamycin)FDA Link 06/2005
1	Polo-Like Kinase 1IBA 04/2005
1	AgarIBA 04/2005

Therapy/Procedure

21	Therapeutics 05/2022 - 04/2005
7	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
1	Chemoradiotherapy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 05/2021